CENTAUR phase 2 trial reveals promising results
CENTAUR phase 2 trial reveals promising results
New findings from the CENTAUR trial show that the drug ‘sodium phenylbutyrate–taurursodiol’…
Read more
Stay in [u]touch[/u]

Stay in touch

Would you like to keep up to date with the latest news from TRICALS? Click on the button below to subscribe to our newsletter

Current developments in clinical trial design and conduct
Current developments in clinical trial design and conduct
Over 70 compounds have been evaluated by clinical studies, yet Riluzole is…
Read more
Reforming clinical studies for ALS
Reforming clinical studies for ALS
In order to find new treatments for ALS, our current strategy for…
Read more
The European Medicines Agency (EMA) endorses TRICALS’ innovative platform trial
The European Medicines Agency (EMA) endorses TRICALS’ innovative platform trial
TRICALS has received the exciting news that the European Medicines Agency (EMA)…
Read more
Second TRICALS Masterclass postponed
Second TRICALS Masterclass postponed
As a result of the continuing global uncertainty caused by the COVID-19…
Read more
Launch of our new TRICALS website
Launch of our new TRICALS website
We are pleased to announce the official launch of our brand-new TRICALS…
Read more